Biotech IPOs ride stock market rollercoaster
This article was originally published in Scrip
Executive Summary
Some of the largest initial public offerings to soar through the open biotechnology IPO window happened just one week after some of the smallest first-time offerings by drug developers, but low-value deals still are seeking a place in the turbulent stock market.